2[2]Johnson RJ,Kang D,Feig DI.Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal diease[J].Hypertension,2003,41(6):1183-1190.
5Abbott RD, Brand FN, Kannel WB, et al. Goutand coronarydisease: the framingham study. J Clin Epidemiol, 1988, 41(3):237-242.
6Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk.N Engl J Med, 2008, 359(17):1811-1821.
7Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factorfor myocardial infarction and stroke:the RotterdamStudy. Stroke, 2006, 37(6):1503-1507.
8Edwards RM, Trizna W, Stack EJ, et al. Interaction of nonpeptideangiotension receptor antagonists with the urate Ⅱ transporter in rat renalbrush border membranes. J Pharmacol Exp Ther, 1996, 276(1):125-129.
9Choi HK,Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia[J].American Journal of Medicine,2007,(05):442-447.
10Niskanen L,Laaksonen DE,Lindstrom J. Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance:the finnish diabetes prevention study[J].Diabetes Care,2006,(03):709-711.
